Results 91 to 100 of about 513,178 (237)

Relevance of anti‐thyroperoxidase antibodies in immune thrombocytopenia in adults: A single‐centre cohort study

open access: yes
British Journal of Haematology, EarlyView.
Nicolas Duhamel   +7 more
wiley   +1 more source

Building a Framework for Sexual and Reproductive Health Care in the Rheumatology Context: Content and Approaches

open access: yesArthritis Care &Research, Volume 78, Issue 10, Page 1510-1521, October 2026.
People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley   +1 more source

The well-defined antiphospholipid syndrome induced by COVID-19: a rare case report and review of the literature

open access: yesThrombosis Journal
COVID-19 may induce a state of hypercoagulability, particularly in critically ill patients, for reasons that remain unknown. Numerous studies have identified the presence of antiphospholipid antibodies in patients with COVID-19; however, the definitive ...
Zong-fang Ren   +5 more
doaj   +1 more source

Antiphospholipid Antibodies [PDF]

open access: yesCirculation, 2005
Caron P, Misita, Stephan, Moll
openaire   +2 more sources

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases

open access: yesArthritis Care &Research, Volume 78, Issue 10, Page 1449-1466, October 2026.
Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci   +25 more
wiley   +1 more source

The possible role of toxoplasmosis in the development of antiphospholipid antibodies in pregnancy-related complications

open access: yesRUDN Journal of Medicine, 2012
The study studied the participation of toxoplasma gondii in the formation of antiphospholipid antibodies in pregnant women. The results showed that previous infection with toxoplasma gondii might lead to development antiphospholipid antibodies, which in ...
- Bayati Ali Hattem Hussein   +1 more
doaj  

Diagnostic Discordance in Recurrent Pregnancy Loss: Hysteroscopy Resolves Ultrasound–MRI Disagreement in Septate Uterus, but Concurrent Ovulation Induction Precludes Causal Attribution of the Reproductive Outcome

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Congenital uterine anomalies are an important and potentially treatable contributor to recurrent pregnancy loss (RPL). The septate uterus is the commonest Müllerian anomaly linked to first‐trimester loss, and its differentiation from the benign arcuate uterus is essential for management, yet imaging modalities may disagree.
Iftekhar Ahmed Sakib   +2 more
wiley   +1 more source

Key Issues at the Forefront of Diagnosis and Testing for Antiphospholipid Syndrome

open access: yesClinical and Applied Thrombosis/Hemostasis
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by antiphospholipid antibodies associated with thrombosis and pregnancy complications.
Jesse Qiao MD   +2 more
doaj   +1 more source

Antiphospholipid Antibodies and Acute-Phase Response in Non-Metastatic Colorectal Cancer Patients

open access: yesThe International Journal of Biological Markers, 2008
Aim To investigate the plasma levels and prevalence of the most common antiphospholipid antibodies, as well as their relationships with several plasma markers of inflammation, in order to characterize some aspects of cancer thrombophilia.
S. Battistelli   +7 more
doaj   +1 more source

Design and Implementation of an Automated Interpretation Algorithm for Lupus Anticoagulant Functional Testing

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 5, Page 1181-1188, October 2026.
ABSTRACT Introduction Lupus anticoagulant (LA) testing is essential, albeit complex, in the laboratory diagnosis of antiphospholipid syndrome (APS). Given the multi‐step workflow and the variability introduced by anticoagulant therapy, reagent differences, and interpretive approaches, result interpretation requires expert evaluation.
Chiara Novelli   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy